JP2010519274A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010519274A5 JP2010519274A5 JP2009550701A JP2009550701A JP2010519274A5 JP 2010519274 A5 JP2010519274 A5 JP 2010519274A5 JP 2009550701 A JP2009550701 A JP 2009550701A JP 2009550701 A JP2009550701 A JP 2009550701A JP 2010519274 A5 JP2010519274 A5 JP 2010519274A5
- Authority
- JP
- Japan
- Prior art keywords
- tnf
- pharmaceutical composition
- composition according
- galactosylceramide
- administered
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000008194 pharmaceutical composition Substances 0.000 claims 4
- VQFKFAKEUMHBLV-BYSUZVQFSA-N 1-O-(alpha-D-galactosyl)-N-hexacosanoylphytosphingosine Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCC(=O)N[C@H]([C@H](O)[C@H](O)CCCCCCCCCCCCCC)CO[C@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O VQFKFAKEUMHBLV-BYSUZVQFSA-N 0.000 claims 2
- 206010028980 Neoplasm Diseases 0.000 claims 1
- 239000002246 antineoplastic agent Substances 0.000 claims 1
- 201000011510 cancer Diseases 0.000 claims 1
- 229940127089 cytotoxic agent Drugs 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP07102787 | 2007-02-21 | ||
| PCT/EP2008/052055 WO2008101951A1 (en) | 2007-02-21 | 2008-02-20 | Combination therapy using tnf and alfa-galactosyl ceramide |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2010519274A JP2010519274A (ja) | 2010-06-03 |
| JP2010519274A5 true JP2010519274A5 (enExample) | 2011-04-07 |
Family
ID=39495301
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009550701A Pending JP2010519274A (ja) | 2007-02-21 | 2008-02-20 | ＴＮＦおよびα−ガラクトシルセラミドを使用する併用療法 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US7959907B2 (enExample) |
| EP (1) | EP2117583B1 (enExample) |
| JP (1) | JP2010519274A (enExample) |
| AU (1) | AU2008219269B2 (enExample) |
| CA (1) | CA2678088A1 (enExample) |
| WO (1) | WO2008101951A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2010519274A (ja) | 2007-02-21 | 2010-06-03 | フラームス・インテルウニフェルシタイル・インステイチュート・フォール・ビオテヒノロヒー・ヴェーゼットウェー（ヴェーイーベー・ヴェーゼットウェー） | ＴＮＦおよびα−ガラクトシルセラミドを使用する併用療法 |
| WO2016065353A1 (en) * | 2014-10-24 | 2016-04-28 | University Of Miami | Combination therapy with fenofibrate and 2-deoxyglucose or 2-deoxymannose |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4677063A (en) | 1985-05-02 | 1987-06-30 | Cetus Corporation | Human tumor necrosis factor |
| US4677064A (en) | 1984-11-09 | 1987-06-30 | Cetus Corporation | Human tumor necrosis factor |
| JPH0559081A (ja) | 1991-08-29 | 1993-03-09 | Kirin Brewery Co Ltd | 新規スフインゴ糖脂質、その製造法および使用 |
| US6001619A (en) | 1995-10-04 | 1999-12-14 | Cold Spring Harbor Laboratory | Ubiquitin ligases, and uses related thereto |
| IL147005A0 (en) | 1999-06-11 | 2002-08-14 | Univ New York State Res Found | Antagonists of bmp and tgfb signaling pathways |
| JP2005533057A (ja) | 2002-06-13 | 2005-11-04 | ニューヨーク・ユニバーシティ | 合成ｃ−糖脂質、ならびに癌、感染性疾患および自己免疫疾患を処置するための合成ｃ−糖脂質の使用 |
| EP1639008A1 (en) | 2003-07-01 | 2006-03-29 | VIB vzw | Ubiquitinated tnf receptor 2 and its uses |
| KR101377116B1 (ko) | 2004-08-27 | 2014-03-24 | 알버트 아인슈타인 컬리지 오브 메디신 오브 예쉬바 유니버시티 | 면역 및 자가면역의 조절제로서의 세라마이드 유도체 |
| JP2010519274A (ja) | 2007-02-21 | 2010-06-03 | フラームス・インテルウニフェルシタイル・インステイチュート・フォール・ビオテヒノロヒー・ヴェーゼットウェー（ヴェーイーベー・ヴェーゼットウェー） | ＴＮＦおよびα−ガラクトシルセラミドを使用する併用療法 |
-
2008
- 2008-02-20 JP JP2009550701A patent/JP2010519274A/ja active Pending
- 2008-02-20 WO PCT/EP2008/052055 patent/WO2008101951A1/en not_active Ceased
- 2008-02-20 AU AU2008219269A patent/AU2008219269B2/en not_active Expired - Fee Related
- 2008-02-20 CA CA002678088A patent/CA2678088A1/en not_active Abandoned
- 2008-02-20 US US12/449,652 patent/US7959907B2/en not_active Expired - Fee Related
- 2008-02-20 EP EP08716968.6A patent/EP2117583B1/en not_active Not-in-force
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA200802012A1 (ru) | Фармацевтические препараты в форме раствора для дозирующих ингаляторов под давлением | |
| JP2013155188A5 (enExample) | ||
| IL203747A (en) | Use of a steroid sex precursor in the manufacture of a 13mg dose or less for daily dosing through the vagina to treat vaginal diseases and a vaginal pharmacological preparation containing it | |
| JP2013541583A5 (enExample) | ||
| CA2683786C (en) | Use of tapentadol in the treatment of pain and with a reduced incidence of tapentadol-induced side-effects | |
| NZ707377A (en) | Combination therapy methods for treating proliferative diseases | |
| EA201270221A1 (ru) | Лечение болезни крона с применением лаквинимода | |
| EA201100313A1 (ru) | Способ доставки фармацевтической композиции пациенту, нуждающемуся в этом | |
| HK1221646A1 (zh) | 高剂量普利多匹定用於治疗亨廷顿舞蹈症的用途 | |
| ME02662B (me) | Niskofrekventna terapija glatiramer acetatom | |
| MX2010005631A (es) | Nuevos compuestos de hidrocarburo ciclicos para el tratamiento de enfermedades. | |
| JP2011079858A5 (enExample) | ||
| JP2012517449A5 (enExample) | ||
| PE20142319A1 (es) | Tratamiento de esclerosis multiple con combinacion de laquinimod y acetato de glatiramero | |
| NZ588913A (en) | Liver cancer drug | |
| JP2018513188A5 (enExample) | ||
| JP2017506624A5 (enExample) | ||
| NZ606993A (en) | Combination pharmaceutical composition and methods of treating and preventing the infectious diseases | |
| NZ605469A (en) | Nalbuphine-based formulations and uses thereof | |
| JP2009515901A5 (enExample) | ||
| JP2013518124A5 (enExample) | ||
| MX2016011333A (es) | Sistemas de administracion de farmaco y metodo para el tratamiento de cancer de vejiga con gemcitabina. | |
| BR112012030641A2 (pt) | métodos e composições para terapia farmacêutica oral | |
| JP2018138596A5 (enExample) | ||
| JP2007119497A5 (enExample) |